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Abstract  
The cytokine leukaemia Inhibitory factor (LIF) promotes self-renewal of mouse 
embryonic stem cells (ESC) through activation of the transcription factor Stat3. 
However, the contribution of other ancillary pathways stimulated by LIF in 
ESCs, such as the MAPK and PI3K pathways, is less well understood. We show 
here that naïve-type mouse ESCs express high levels of a novel effector of the 
MAPK and PI3K pathways. This effector is an isoform of the Gab1 (Grb2-
associated binder protein 1) adaptor protein that lacks the N-terminal Pleckstrin 
Homology (PH) membrane-binding domain. Although not essential for rapid 
unrestricted growth of ESCs under optimal conditions, the novel Gab1 variant 
(Gab1) is required for LIF-mediated cell survival under conditions of limited 
nutrient availability. This enhanced survival is absolutely dependent upon a 
latent palmitoylation site that targets Gab1 directly to ESC membranes. These 
results show that constitutive association of Gab1 with membranes through a 
novel mechanism promotes LIF-dependent survival of murine ESCs in nutrient 
poor conditions. 
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Introduction 
Embryonic stem cell (ESCs) are pluripotent cell lines derived from the inner cell 
mass of the blastocyst (Boeuf et al., 1997; Martello et al., 2013; Matsuda et al., 
1999; Niwa et al., 1998; Niwa et al., 2009; Ye et al., 2013). They are immortal, 
differentiate into all foetal cell types in vitro, and most remarkably when 
reintroduced into an appropriately staged embryo reinitiate normal development 
to form all foetal tissues, including the germ line (Martello and Smith, 2014). 
These characteristics make ESCs a powerful experimental system and 
underpin their potential as a biomedical resource that can provide unlimited, 
scalable sources of normal cell-types for regenerative therapy and drug 
screening.   
The biological capacity and value of ESCs relies upon the fidelity with which 
their developmental potential can be maintained in culture and as a 
consequence, considerable efforts have been made to understand the role of 
self-renewal signals and the transcriptional factors that maintain ESC 
pluripotency (Ying and Smith, 2017). The cytokine LIF plays a crucial role in 
promoting self-renewal of mouse ESCs and the signals it elicits have also been 
shown to have an important physiological role in supporting preimplantation 
mouse development (Nichols et al., 2001). Although the requirement for this 
cytokine in ESCs of other species is unclear,  LIF is included as a supplement 
in culture media that support human stem cell lines thought to be equivalent to 
mouse ESCs, and non-rodent pluripotent stem cells can respond to LIF, 
suggesting that this cytokine signalling pathway may have a general role in 
supporting pluripotent stem cells of mammals (Guo et al., 2016; Takashima et 
al., 2014; Theunissen et al., 2014; Thomson et al., 2012). 
LIF-dependent signalling is initiated by heterodimerization of LIF receptor with 
gp130, leading to cross-phosphorylation of receptor associated JAK tyrosine 
kinases. The activated kinases then phosphorylate specific receptor tyrosines 
that in turn serve as docking sites for the recruitment and activation of 
downstream effectors.  The key effectors include the transcription factor Stat3, 
which activates expression of target genes directly, and the tyrosine protein 
phosphatase SHP2, which triggers the Erk MAPK cascade and 
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phosphatidylinositol 3-kinase (PI3K) signalling. Although studies have shown 
that Stat3 activation of the target genes Tfcp2L1, KLF4, and Gbx2 are critical 
for effective ESC self-renewal (Ying and Smith, 2017), the contribution of LIF 
activation of Erk MAPK and PI3K in ESC is less clear. Initial studies showed 
that the SHP2 activation was not essential for self-renewal and that general 
suppression of Erk MAPK signalling restricts mESC differentiation (Burdon et 
al., 1999). Indeed, suppression of Erk signalling when combined with activation 
of wnt/-catenin signalling very effectively promotes  self-renewal of 
undifferentiated  ESCs (Buehr et al., 2008; Li et al., 2008; Wray et al., 2011; 
Ying et al., 2008). This 2-inhibitior (2i) culture system is enhanced further by the 
addition of LIF, suggesting that Stat3 or other LIF-induced signals are required 
to support efficient and robust propagation of ESCs (Dunn et al., 2014; Li et al., 
2008; Ying et al., 2008).  
A candidate mediator of LIF receptor signalling is Gab1 (Grb2-associated 
binder protein 1), an Insulin Receptor Substrate (IRS)/Daughter of Sevenless 
(DOS) family adaptor protein (Holgado-Madruga et al., 1996; Weidner et al., 
1996). In common with other IRS/DOS proteins, Gab1 has no intrinsic 
enzymatic activity but functions as molecular scaffold to recruit and assemble 
signalling complexes. Gab1 is an important mediator of Erk, PI3K and PLC 
signalling induced by many growth factors - including the LIF/IL-6-related 
cytokines (Nishida and Hirano, 2003; Takahashi-Tezuka et al., 1998). The key 
functional elements of Gab1 include a membrane binding activity encoded by 
the N-terminal pleckstrin homology (PH) domain, and an extended unstructured 
C-terminal region that mediates protein-protein interactions with other signalling 
molecules. The 110 amino acid PH domain contains seven -sheets capped off 
with a short amphipathic -helix, forming a classic PH-fold that contains a 
binding site for the phospholipid product of PI3K, phosphatidylinositol (3,4,5)-
triphosphate (PIP3) (Maroun et al., 1999a). Although initial recruitment of Gab1 
to activated receptors is mediated through protein-protein interactions, tyrosine 
phosphorylation of Gab1 by receptor-activated kinases generates docking sites 
for PI3K, which in turn produces the PIP3 phospholipid ligand for the Gab1 PH 
domain. This PI3K/PH domain-dependent positive feedback loop stabilises the 
interaction between Gab1 and activated receptors and amplifies downstream 
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signals such as Erk via recruitment of SHP2 (Rodrigues et al., 2000). Previously 
we have shown that Gab1 is phosphorylated by activation of the gp130 receptor 
in mouse ESC (Burdon et al., 1999). Here we report the predominant form of 
Gab1 in mESCs is an unusual variant that lacks most of the conserved PH 
domain including the PIP3 phospholipid binding site. Nevertheless, we 
unexpectedly find that this novel form of Gab1 is constitutively associated with 
ESC membranes and specifically promotes LIF mediated ESC survival under 
conditions where nutrient availability is limited. 
 
Results 
A novel short form of the Gab1 adaptor protein is highly expressed in 
ESCs  
Stimulation of mouse ESC via the  gp130 cytokine receptor induces 
phosphorylation of the Gab1 adaptor protein (Burdon et al., 1999). However, 
the apparent molecular weight of Gab1 protein in mESCs, based on 
electrophoretic mobility, was significantly less than the 110-115 kDa reported 
for Gab1 protein of differentiated somatic cells (Burdon et al., 1999; Holgado-
Madruga et al., 1996; Weidner et al., 1996). To understand the basis of this 
difference we compared Gab1 expression in mESC with other embryonic cell 
types by western blotting and found that the predominant form of Gab1 protein 
in ESC and embryonal carcinoma cells was ~95 kDa, whereas embryonic 
fibroblasts and pooled tissues of a mid-gestation embryo possessed the typical 
110-115 kDa form (Fig. 1A). Coordinate downregulation of a 4.5 kb Gab1 RNA 
and the 95 kDa Gab1 protein during embryoid body differentiation implied that 
the short-form Gab1 was encoded by this ESC specific mRNA (Fig. S1A, B). 
We therefore sequenced Gab1 cDNAs obtained from an ESC cDNA library and 
found that all clones possessed a novel ~50 nucleotide non-coding 5’ exon not 
present in the previously reported Gab1 cDNA, which is located ~ 20 kb 
downstream from the first exon containing the established Gab1 translation 
start codon (Fig. 1B S1C). Apart from the novel 5’ non-coding exon, the 
predicted protein coding sequences of the ESC Gab1 cDNAs was identical to 
that previously reported for mouse Gab1, suggesting that translation of the ESC 
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Gab1 protein initiates at methionine codon  downstream of the normal Gab1 
start codon. To identify this novel start codon, we transiently transfected COS7 
cells with a series of Gab1 cDNAs where translation was initiated at each of the 
first 4 in-frame ATG codons. Initiation at the most 5’ methionine, M104, 
produced a Gab1 protein of similar mobility to that present in ESC protein 
lysates. (Fig. S1D). Methionine 104 is situated at the C-terminal boundary of 
the Gab1 PH domain (aa 10-117), and translation initiation from M104 
eliminates most of this critical regulatory domain (Fig. 1C). The N-terminal 
located PIP3 binding site that mediates membrane localisation, and a less well 
characterised putative nuclear localisation sequence are also eliminated 
(Maroun et al., 1999b; Osawa et al., 2004). Nonetheless, the 95 kDa protein 
should retain all of the recognised direct protein-protein binding sites for 
partners such as Grb2, the MET receptor, PI3K and SHP2 and for our purposes 
will be referred to as Gab1, to distinguish it from the previously characterised 
longer form, Gab1.   
To investigate how closely Gab1 expression was associated with the ESC 
state, we examined expression of the adaptor protein during induced pluripotent 
stem cell (iPSC) reprogramming of embryonic fibroblasts, and during exit from 
naive pluripotency to the “primed” pluripotent state representative of post-
implantation epiblast stem cells (EpiSC). Western blotting showed that Gab1 
was not expressed in partially reprogrammed pre-iPSCs (Fig. 1D), but was 
readily detected when cells transitioned to fully reprogrammed iPSCs derived 
either using standard serum/LIF, or the more stringent two inhibitor (2i) 
condition that promotes the ‘naive’ ESC  ground state (Boroviak et al., 2014; 
Boroviak et al., 2015; Nichols and Smith, 2009). In contrast, Gab1 expression 
was absent from EpiSCs derived from post implantation embryos (Fig. 1D). The 
association of Gab1 with the naïve ESC state was further confirmed by 
monitoring the levels of Gab1 transcripts during the transition of an ESC line 
through a stable EpiSC state and into differentiated embryoid bodies (Fig.1E). 
Whereas expression of Gab1 increased as the ESCs transitioned to the 
primed state and then differentiated, Gab1 transcripts were sharply 
downregulated upon exit from the naïve ESC state, in line with the loss of 
Gab1 protein expression from the post-implantation epiblast derived cells (Fig 
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1D). Interestingly, these switches in Gab1 transcription are also reflected in 
changes in epigenetic status of putative Gab1 promoters (Fig S1E). In naïve 
ESCs, H3K4me3 histone methylation associated with active promoters is 
enriched at the region immediately upstream of the Gab1 first exon, whilst the 
Gab1 promoter region, by contrast, is enriched for the repressive H3K27me3 
mark commonly associated with gene silencing.  
To determine whether Gab1 was expressed during preimplantation 
development in vivo we performed RT-PCR amplification on mouse embryos 
and detected transcription of the novel 5’ exon of Gab1 in both fertilised 
oocytes and blastocysts (Fig. S2A). Gab1transcription was also detected in 
primordial germ cells and western blotting indicated a low level expression of 
the 95 kDa protein in the adult testis (Fig. S2A, B). By contrast, Gab1 protein 
was not readily detected in most other adult mouse tissues suggesting that high 
level expression was primarily restricted to ESCs and germ cells (Fig. S2B).  
Gab1 transcripts containing alternative 5’ exons have also been found in EST 
cDNA libraries in animals ranging from frogs to humans (Fig. S1C). The 
corresponding Gab1 exon in mouse was identified by Cap-Analysis of Gene 
Expression (CAGE), a technique that maps 5’ transcription initiation sites, 
providing evidence that a promoter within intron 1 drives expression of 
Gab1(Fig. S2C). Transcription initiation at this site was also detected in 
trophoblast stem cell lines suggesting that while this variant form of Gab1 
protein is enriched in ESCs, expression may not be exclusive to pluripotent cells 
of the early mouse embryo.  
  
Gab1 promotes LIF-dependent signalling in ESCs 
To evaluate the contribution of Gab1 to signalling in ESCs we first examined 
tyrosine phosphorylation of Gab1 in response to the growth factor 
supplements LIF and foetal calf serum used in routine ESC cultures (Fig. 2A, 
B). Western blotting of Gab1 immunoprecipitates showed that the overall level 
of Gab1 tyrosine phosphorylation increased only slightly in response to LIF or 
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serum. In contrast however, tyrosine phosphorylation at specific SHP2 (Y627) 
and PLC (Y307) binding sites increased markedly in response to LIF 
demonstrating that Gab1 is phosphorylated at recognised docking sites 
following stimulation of the LIF receptor. Consistent with this phosphorylation 
pattern, SHP2 immunoprecipitates from LIF-induced ESC contained 
Gab1(Fig. 2B). Gab1 was also constitutively associated with the adaptor 
proteins p85 (non-catalytic subunit of PI3-Kinase), Grb2 and ShcA in ESCs 
(Fig.  S3A, B).  
Without the PH domain to stabilise association with the plasma membrane 
Gab1 might not be able to effectively propagate downstream signals since 
theoretically the adaptor protein should be unable to participate in the PH 
domain/PI3K/PIP3-dependent amplification mechanism (Rodrigues et al., 
2000). Gab1 might even operate as a molecular sponge or decoy to dampen 
downstream effector functions. To determine how Gab1 influences 
downstream signalling we generated ESC lines that specifically lack Gab1 but 
retain Gab1 expression. This was achieved by two consecutive rounds of 
homologous recombination with targeting vectors in which hygromycin and 
blasticidin resistance genes were inserted into the unique Gab1 5’ exon (Fig. 
S3C, D, E).  
To assess the role of Gab1 in LIF signalling we examined phosphorylation of 
Akt, Erk and Stat3 in wild type ESCs, in Gab1 KO ESC, and in KO clones 
where we either restored Gab1 expression, or over-expressed Gab1 using 
stably integrated cDNA expression vectors (Fig. 2C). Whilst LIF-stimulated 
Stat3 phosphorylation was similar in all cell lines, the induction of Akt and Erk 
phosphorylation by LIF was noticeably reduced in Gab1 KO ESC compared 
with Gab1 wild-type ESC. However, reconstitution of Gab1 or over-
expression of Gab1 in Gab1 KO cells increased both Akt and Erk 
phosphorylation compared with Gab1 KO cells. In contrast, Gab1 expression 
did not appear to play a significant role in serum-induced phosphorylation of 
Erk (Fig. S3F, G). These results demonstrated that despite not having a PH 
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domain, Gab1contributes to signalling downstream of the LIF receptor in 
ESCs. 
  
Gab1 expression provides a growth advantage in high density ESC 
cultures  
To assess the biological function of Gab1 in ESC we first examined stem cell 
self-renewal, making use of the ESC-specific Pou5f1-geo knock-in allele in the 
IOUD2 parental  ESC line, that allows the growth of undifferentiated stem cells 
to be monitored by measuring  Pou5f1-LacZ derived -galactosidase activity 
(Mountford et al., 1994). We compared -galactosidase activity in wild-type and 
Gab1 KO IOUD2 cells in self-renewal assays and found that the cell lines 
exhibited similar levels of self-renewal in response to different concentrations 
of LIF (Fig. S4A), indicating that Gab1 expression did not affect ESC self-
renewal at the low cell densities used in these self-renewal assays.  
To investigate whether Gab1 expression affects ESC growth at higher cell 
densities we examined the behaviour of Gab1-deficient ESCs in near 
confluent cultures.  We used Gab1 mutant cell lines generated from the 
standard wild-type E14Tg2a parental cells (Fig S4B, C), to exclude concerns 
that genetic modification of the Pou5f1 gene might affect the response of cells 
in high density assays (Karwacki-Neisius et al., 2013). Consistent with the 
previous IOUD2 experiments, self-renewal assays in the E14Tg2a Gab1 
expressing and deficient KO lines did not reveal consistent differences between 
lines (Fig. S4D). When we plated two independent Gab1 heterozygous and 
two Gab1 KO E14Tg2a clones at densities typical of those routinely used for 
propagating ESC lines (~105 cells/cm2) the initial growth of the cell lines was 
indistinguishable in the first 2-3 days. However, once the lines approached 
confluence it appeared that the survival of Gab1 expressing heterozygous 
cells was noticeably greater than that of the Gab1 KO cells (Fig 3A).   
Monitoring ESC growth by measuring live cell DNA-dependent fluorescence 
daily throughout a 6-day culture period confirmed that the growth of all four 
clones was very similar for the first 2 days. However, between the 3rd and 4th 
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days, when cell growth slowed, the Gab1 expressing heterozygous cells 
attained higher cell numbers and maintained these higher levels for an 
extended period (Fig. 3B). Statistical analysis showed that from day 3 onwards, 
the mean live cell DNA fluorescence differed significantly between the Gab1 
heterozygous and KO cells. To confirm that this effect was due to Gab1 
expression we repeated the growth experiments using pools of Gab1 KO cells 
stably transfected with either a Gab1 expression vector or an EGFP control, 
and compared them with a pool of Gab1 heterozygous clones transfected with 
a mCherry expression control vector (Fig. 3C). As with previous experiments, 
the cell lines showed similar rates of growth during the first two days, but 
between days 3-4 the Gab1 restored and heterozygous cells exhibited a 
growth or survival advantage over the KO cells lacking Gab1. There was a 
statistically significant difference between the live cell DNA fluorescence in 
EGFP control and Gab1 expressing cells between day 4-6, but not between 
the Gab1 heterozygous mCherry-transfected cells and Gab1 expressing 
cells. Collectively, these results establish that Gab1 expression provides a 
growth or survival advantage in high cell density culture conditions. 
 
Gab1 promotes ESC survival in nutrient depleted conditions 
To determine the cause of the growth advantage associated with Gab1 
expression we examined cell proliferation and apoptosis in the near-confluent 
ESC cultures. The cell cycle profiles of Gab1 expressing and non-expressing 
cells were determined by measuring DNA content by flow cytometry. The 
overall profiles were indistinguishable during either the rapid or plateau growth 
phases, although as expected, there was a noticeable reduction in the S-phase 
contribution in both cell types during the plateau phase (Fig. 4A). However, it 
was evident that Gab1 KO cells accumulated a greater amount of sub-
diploid/fragmented cells at day 3 during the plateau growth phase, pointing to 
increased levels of cell death in these cultures (Fig. 4A, B). We therefore used 
flow cytometry to assess the level of apoptosis by measuring the percentage of 
live cells that were positive for the apoptotic maker Annexin V. While equivalent 
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levels of early apoptosis were observed at day 1 in both ESC cultures, at day 2 
there was a marked increase in Annexin V staining in the Gab1-deficient KO 
cells, (Fig. 4C).  Caspase 3/7 activation and cytotoxicity, reflecting general cell 
death, were both noticeably higher in the day 2/3 Gab1 KO cultures further 
supporting the notion that absence of Gab1 was associated with increased 
levels of apoptosis (Fig. 4D). Taken together these results suggest that 
expression of the Gab1 protein in ESCs promotes cell survival when culture 
conditions become restrictive.    
In high-density cultures a number of factors including environmental, physical 
or metabolic might limit ESC growth. To distinguish between these alternatives 
we modified the culture environment and monitored the effects on ESC growth. 
To investigate what factors affect the growth profile, we treated ESC with an 
inhibitor of the enzyme mTOR (mammalian/mechanistic target of rapamycin), a 
key enzyme that senses and controls nutrient availability in cells, and is a 
regulator of anabolic process such as protein, lipid and nucleotide synthesis 
(reviewed in (Saxton and Sabatini, 2017) ) . Addition of 25 nM mTOR inhibitor 
(INK128) restricted the initial growth rate of Gab1 expressing and non-
expressing cells equally and reduced the maximum cell numbers achieved in 
both cases (Fig 5A). Under these restrictive conditions the growth/survival 
advantage of the Gab1 expressing cells was still apparent, even though it 
occurred at a lower cell numbers, implying that it was unlikely that cell density 
was responsible for limiting the later phase of ESC growth.   
To determine whether nutrients might be limiting the growth of Gab1deficient 
ESCs, we tested how supplementation with medium components affected ESC 
culture growth and survival at the plateau phase (Fig 5B, C). Addition of either 
standard DMEM, or DMEM lacking glucose, sodium pyruvate and glutamate at 
day 2 of the culture improved the survival of Gab1 KO ESCs, suggesting that 
depletion of amino acids or vitamin supplements common to both growth media 
become limiting for ESC growth during the plateau phase, and excluded the 
depletion of energy sources such as glucose as being directly responsible for 
slowing ESC growth. Direct supplementation of plateau phase cultures with 
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glutamine or sodium pyruvate also did not appreciably improve ESC 
survival/growth, (Fig. S5).  
 
Gab1 mediated ESC survival is LIF-dependent 
We have shown that Gab1 is phosphorylated after stimulation of the LIFR, and 
activates downstream signalling (Fig. 2). To determine whether LIF signalling 
was also required for Gab1-mediated ESC survival in nutrient-depleted 
cultures we compared the growth of Gab1 expressing and non-expressing 
cells with or without LIF during the 6-day cultures. Whereas cells in all 
conditions grew rapidly for the first two days, in both Gab1 expressing and KO 
cultures deprived of LIF cell numbers declined rapidly after this point in a 
manner similar to that displayed by Gab1 KO cells cultured in the presence of 
LIF (Fig. 6A). This demonstrated that ESC survival in post-confluent cultures 
relies on LIF signalling, and is also effected by Gab1 expression. Although 
unlikely, it is possible that the loss of cell viability seen here is a result of ESC 
differentiation initiated by LIF withdrawal. To address this possibility, we 
restricted ESC differentiation by including the Mek inhibitor PD0325901 in the 
LIF-deficient high density cultures. However, this did not improve ESC survival 
(Fig. 6A), and may even have compounded the effects of LIF withdrawal. To 
explore the relationship between Gab1 and LIFR-mediated cell survival, we 
examined the LIF dose response of ESC cultures (Fig. S6 A, B). Whereas the 
survival of the Gab1 expressing cells at the plateau phase was dependent on 
the dose of LIF, the acute collapse in viability of the majority of the Gab1 KO 
cells was largely dose-independent. 
 
Survival of Gab1 KO ESCs is rescued by inhibition of FGFR or Mek 
activity  
The studies above were performed under standard serum + LIF culture 
conditions, but we were interested in determining how Gab1 expression might 
affect ESC growth and survival under culture conditions, such as 2i+LIF, that 
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selectively promote the naïve ESC state. We found that while cell proliferation 
in the initial growth phase was similar to that in serum-containing medium (Fig. 
6B), in the post-plateau phase, Gab1 KO cell survival in 2i+LIF medium was 
markedly better than in serum +LIF medium, and comparable to cells 
expressing Gab1. There were differences in growth characteristics of ESCs in 
2i+LIF serum-free and serum + LIF media - with 2i+LIF cells forming more 
compact and tight colonies.  Nonetheless these results indicate that conditions 
induced by 2i+LIF compensate for the absence of Gab1 in the Gab1 KO cells. 
To determine how 2i+LIF contributes to this “rescue” effect we inhibited either 
Mek or its upstream activator FGFR (fibroblast growth factor receptor) in the 
standard serum +LIF conditions. Treatment of cells with Mek inhibitor or the 
FGFR inhibitor PD173074 had little effect on the initial rate of expansion of 
ESCs but in both cases improved the survival of the Gab1KO cells (Fig. 6C, 
D). Taken together these results indicate that the survival function of Gab1 
and the inhibition of FGFR/Mek dependent activities converge to promote ESC 
survival.   
                 
Gab1 is located at ESC membranes 
Localisation of Gab1 at the cell membrane is thought to be critical for its 
functional activity and yet, despite lacking an intact PH domain, Gab1 
contributes to ESC signalling and promotes ESC survival. To understand how 
Gab1 could influence ESC survival without the PH domain, we examined the 
cellular location of Gab1 in ESCs. Based on previous reports a Gab1 protein 
lacking the phospholipid binding site contained within the PH domain should be 
located in the cytoplasm (Maroun et al., 1999b; Rodrigues et al., 2000). 
However, when we compared the location of Gab1 protein in wild-type and 
Gab1 KO ESC by immunocytochemistry (using the antibody that recognises 
both Gab1 and  forms), it was clear that in wild-type cells a significant 
proportion of Gab1 protein was at the cell membrane (Fig. 7A). By contrast, in 
Gab1 KO cells there was very little membrane-associated Gab1 protein (Fig. 
7B). Crucially, stable expression of a Gab1 cDNA in the KO cells restored the 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
wild-type distribution of Gab1, demonstrating that Gab1 in ESCs is normally 
located at the cell membrane (Fig. 7C).  
To determine how Gab1 is directed to the membrane we examined the cellular 
localisation of Gab1-EGFP fusion proteins stably expressed in the Gab1 KO 
cells. Whereas the Gab1-EGFP fusion protein carrying EGFP at the C-
terminus of Gab1 was located predominantly at the ESC membrane (Fig. 7D), 
the corresponding Gab1-EGFP protein was largely cytoplasmic, with only a 
minority of ESCs displaying membrane associated Gab1-EGFP (Fig. 7E). 
Significantly, a fusion protein in which EGFP was attached to the N-terminus of 
Gab1 was entirely cytoplasmic (Fig. 7F). This result suggested that the 
membrane targeting signal of Gab1can be blocked by attachment of EGFP, 
or the PH domain, and is therefore is likely to be located close to the N-terminus 
of the protein. 
Gab1 proteins that lack the entire PH domain (amino acids 10-117)  have been 
shown to be located in the cytoplasm (Maroun et al., 1999b; Rodrigues et al., 
2000). However, these artificial mutants are not directly comparable to 
Gab1expressing cells as we noted that the N-terminus of Gab1 retains an 
additional 15 amino acids (15 aa) from the end of the PH domain. This 15 amino 
acid polypeptide forms a structurally conserved amphipathic helix that typically 
caps off PH domains (Lemmon and Ferguson, 2000). To examine the 
contribution of this 15 aa polypeptide we deleted this element from the Gab1-
EGFP fusion protein and found in agreement with previous reports (Maroun et 
al., 1999b; Rodrigues et al., 2000) the Gab1-15aa-EGFP protein was located 
in the cytoplasm (Fig. 7G). To examine directly how the N-terminal region of 
Gab1 contributes to membrane targeting, we examined the localisation of 
EGFP fusion proteins carrying the N-terminal 47 amino-acids (aa104-150) or 
just the 15 amino acid peptide (104-118) of Gab1 (Fig.  7H, I).  The 47aa-
EGFP protein was very clearly located at the membrane. In comparison, the 
15aa-EGFP fusion protein exhibited a weaker signal at the membrane and 
evidence of irregular distribution throughout the cytoplasm. Taken together 
these experiments suggest that the N-terminal region of Gab1 containing the 
residual 15 aa alpha helical region derived from the PH domain, is sufficient to 
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target Gab1 to the ESC membrane. Gab1 protein also accumulated at an 
intracellular site in most ESCs (Fig. 7 A, C), as did the Gab1-EGFP and 47aa-
EGFP fusion proteins (Fig. 7D,H)  indicating that Gab1 may also associate 
with the membranes of intracellular vesicles. 
 
Palmitoylation of Gab1 drives its membrane localisation and function  
Our localisation experiments demonstrate that the 15 aa N-terminus of Gab1 
contains a signal that targets it to ESC membranes. Examination of this region 
identified three cysteines that were potential sites for palmityolyation, a lipid 
modification that could account for the stable association of Gab1 with the cell 
membrane (Fig. 8A). The three cysteines are conserved to different extents 
amongst Gab family members, including the Gab1 homolog DOS present in 
Drosophila, and SOC-1 in Caenorhabditis. To test directly whether Gab1 is 
palmitoylated in ESCs, we cultured ESCs expressing Gab1-EGFP fusion 
proteins in the presence of 3H-palmitate and examined 3H-labelling of EGFP 
immunoprecipitates after electrophoresis and transfer to an immobilising filter. 
Autoradiography revealed that Gab1 and the 47aa fusion constructs were 
labelled efficiently with 3H-palmitate (Fig. 8B). By contrast, deletion of the 15aa 
region from Gab1, or alanine substitution of the three cysteines in 47aa fusion 
protein (47aa-CA3m-EGFP), prevented labelling. Interestingly, 3H-labeling of 
Gab1 or Gab1 PH domain-EGFP fusion proteins could not be detected, 
demonstrating that in the presence of the intact PH domain Gab1 palmitoylation 
is suppressed or at least was inefficient under these experimental conditions. 
To determine how palmitoylation of Gab1 affects membrane targeting, we 
examined the localisation of the 47aa-CA3 mutant–EGFP in ESC and found 
that alanine substitution of the three cysteines in this mutant abolished 
membrane targeting of the fusion protein (Fig. 8C). Significantly, the identical 
alanine substitutions within the context of the PH domain-EGFP fusion protein 
did not prevent localisation at the membrane (Fig. 8C).   
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 These results strongly suggest that palmitoylation of the N-terminal domain 
drives membrane localisation of Gab1 in ESC. We therefore determined 
whether palmitoylation of Gab1 was also associated with supporting ESC 
survival. We compared the growth of Gab1 KO ESCs with cells stably 
expressing cDNAs encoding either Gab1 or a Gab1-CA3 mutant. In contrast 
to cells expressing wild-type Gab1, ESCs expressing the Gab1-CA3 mutant 
protein exhibited the same growth profile as the Gab1 KO cells, showing that 
the palmitoylation of Gab1 and localisation at the ESC membrane is required 
for Gab1-dependent ESC survival in culture (Fig.  8D). 
  
Discussion  
LIF receptor/gp130 signalling has essential roles during early embryonic 
development that provide the physiological rationale for the contribution of this 
signalling pathway to the growth and self-renewal of embryonic stem cells 
(ESCs) in culture (Do et al., 2013; Nichols et al., 2001). Here we report the 
identification of a novel variant form of the adaptor protein Gab1 (Gab1) that 
contributes to LIF-dependent survival of ESCs under conditions of limited 
nutrient availability. In this Gab1 variant the domain that normally regulates the 
access of the protein to the membrane and to activated receptors is replaced 
by a lipid tag that anchors the Gab1 adaptor protein constitutively at the cell 
membrane. Although disruption of Gab1 expression does not normally disturb 
pre-gastrulation embryo development, we presume the switch in regulatory 
modes may confer an additional growth or survival advantage under 
exceptional circumstances (Itoh et al., 2000; Sachs et al., 2000). Since Gab1 
is expressed in cells representative of the early preimplantation epiblast and 
the trophoblast stem cell compartment, we speculate that a primary function of 
Gab1 is to support preimplantation embryos exposed to suboptimal 
environmental conditions in the uterus. 
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The abundance of Gab1 protein and its phosphorylation following treatment 
with LIF pointed to the adaptor protein having a functional role in ESCs.  Under 
the standard clonal culture conditions typically used to assess growth and self-
renewal, ESCs tolerated the loss of Gab1. However, when challenged with 
nutrient-limited conditions, Gab1 expression reduced cell death and extended 
the viability of ESCs. When cells were treated with an inhibitor of the key 
nutrient sensor and anabolic regulatory enzyme mTOR Gab1 expression 
improved ESC survival, which could imply that availability of nutrients is a 
contributory limiting factor. Indeed, rescue of starved ESC cultures by 
supplementation with minimal basal medium indicated that either lack of amino 
acids or vitamins was responsible for collapse of the cultures. It has been 
reported that restricting ESC growth induces a state that resembles the 
quiescent condition induced in embryos during delayed implantation (also 
known as diapause) (Renfree and Shaw, 2000). In the natural condition, 
preimplantation blastocysts undergo developmental arrest and implantation is 
delayed in order to synchronise embryo development with the mother’s 
reproductive capacity and environmental inputs. Importantly, inhibition of 
mTOR is reported to suppress ESC growth and to maintain a “paused” 
quiescent, but developmentally competent, state in ESCs and blastocysts for 
over a week (Bulut-Karslioglu et al., 2016). This suggests that nutrient 
availability may determine entry into this quiescent condition and this state can 
be induced experimentally in culture.  
The survival function of Gab1 in ESCs was evident in LIF treated cultures. 
Gab1 expression also increased LIFR-mediated Erk and Akt phosphorylation, 
implicating the adaptor directly as a transducer of LIF receptor signals. PI3K/Akt 
signalling has been shown to be involved in Gab1-mediated cell survival and in 
ESCs activation of this pathway has been reported to promote cell growth, 
survival and self-renewal (Cherif et al., 2015; Fan et al., 2016; Fukumoto et al., 
2009; Furuta et al., 2016; Hishida et al., 2015; Holgado-Madruga and Wong, 
2003; Holgado-Madruga et al., 1997; Jirmanova et al., 2002; Paling et al., 2004; 
Sun et al., 2014; Watanabe et al., 2006). By contrast, Erk activation is normally 
associated with ESC differentiation, and inhibition of Mek/Erk signalling 
promotes ESC self-renewal (Burdon et al., 1999; Ying et al., 2008). Notably, 
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inhibition of either FGFR or Mek activity improved the survival of Gab1-KO 
ESCs, and appeared to largely rescue the Gab1 deficiency. Indeed, it has 
been reported that Mek inhibition reduces the requirement for PI3K signalling 
in ESC, thus potentially uncoupling cells from the requirement for PI3K-
dependent survival signals provided by Gab1 (Hishida et al., 2015). A possible 
alternative explanation is that Gab1 might represent a physiological disruptor 
of Mek signalling by altering the activation kinetics of the pathway, or by binding 
Erk and regulating access of this kinase to its target proteins (Osawa et al., 
2004; Wolf et al., 2015).   
Membrane localisation of Gab1 is essential for its survival function and is 
dependent on palmitoylation of this ESC adaptor protein. The lipid modification 
targets Gab1 to ESC membranes, liberating Gab1 from dependence on PI3K 
activity and availability of the phospholipid PIP3, and locates the adaptor in 
close proximity to upstream effectors such as receptors and associated 
kinases. Removal of the PH domain also eliminates an auto-inhibitory 
interaction between the PH domain and C-terminal region of Gab1 (Eulenfeld 
and Schaper, 2009; Wolf et al., 2015). This blocks PIP3 binding by the PH 
domain, but can be relieved by Erk-mediated phosphorylation of the C-terminal 
domain. Freed from this regulatory constraint, Gab1 should be constitutively 
available to associate with receptors and maintain the basal level of Gab1 
phosphorylation observed in ESCs. Nonetheless, Gab1 cannot participate in 
the PH domain/PI3K/PIP3 positive feedback loop and therefore will be limited 
in its capacity to amplify downstream signalling. Understanding why Gab1 
expression is preferred in ESCs rather than simply upregulating Gab1 
expression should provide insights into how quantitative and qualitative aspects 
of signalling affect cell behaviour in the early embryo. Perhaps direct 
association of Gab1 with the cell membrane increases sensitivity to LIF 
receptor/gp130 mediated activation, but limits the intensity and duration of 
signalling to curb differentiation or proliferation - thus supporting stem cell 
survival under growth restrictive conditions.   
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 Gab variants with alternative N-terminal sequences have been described 
previously. A hamster Gab1 protein (Gab11-103) analogous to Gab1, 
enhances anchorage-independent growth of preneoplastic fibroblasts (Kameda 
et al., 2001), and PH-domain deficient isoforms have also been reported for the 
closely related Gab-family member Gab2 (Adams et al., 2012; Gu et al., 1998; 
Gu et al., 2001). Interestingly, membrane localisation of another IRS/DOS 
family member, Fibroblast Growth Factor Receptor Substrate 2 (FRS2) 
depends  upon myristylation to target this adaptor protein to the cell membrane 
and enable its participation in downstream signalling (Kouhara et al., 1997). 
Gab protein variants may therefore exemplify a more general mechanism for 
diversifying the intracellular locations of this class of adaptor proteins and their 
contribution to signalling. 
Gab1 is highly expressed in “ ground state” naive ESCs that are thought to 
closely represent the epiblast of the preimplantation embryo  (E3.75-E4.5) 
(Boroviak et al., 2014).  Interestingly, although Gab1 expression is down-
regulated during the transition to form EpiSCs, a cell type representing the post-
implantation epiblast (Brons et al., 2007; Tesar et al., 2007), high levels of 
Gab1 transcription are also detected in trophoblast stem cells. This may 
indicate that Gab1 transcription is regulated by factors common to both 
epiblast and trophoblast stem cells, and additionally point to Gab1 having a  
broader role in regulating the viability of cells within the whole preimplantation 
embryo.  
In conclusion, Gab1 is highly expressed in rodent ESCs and supports LIF-
dependent survival when nutrient availability becomes limiting. How Gab1 and 
its downstream effectors interact with the regulatory machinery of cells in the 
preimplantation embryo, and their relevance to conditions prevalent in vivo 
deserves further consideration and could provide new insights into the control 
of embryo survival.     
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 Materials and Methods 
Cell culture and transfections 
ESCs were cultured without feeder cells in Glasgow modification of Eagle’s 
medium (GMEM) containing 10% foetal calf serum, 0.1 mM 2-mercaptoethanol 
and LIF as described previously (Chambers et al., 2003; Hooper et al., 1987; 
Mountford et al., 1994; Niwa et al., 2000; Smith, 1991). R2 pre-iPS cells were 
cultured on irradiated DIAM feeders (Meek et al., 2010) in GMEM/FCS 
(Theunissen et al., 2011). iPS cells were cultured in 2i+LIF medium 
(Theunissen et al., 2011) or with GMEM/FCS/LIF as described for ESC above. 
EpiSC cells were grown on fibronectin coated plates in N2B27 medium 
containing Activin (20 ng/ml) and FGF2 (12 ng/ml) (Guo et al., 2009; Osorno et 
al., 2012). PSMB embryonal carcinoma, primary mouse embryonic fibroblasts, 
COS7, NIH 3T3 and C3H 10T1/2 cells were maintained in ESC culture medium 
without LIF. For routine ESC culture LIF was generated in house. For inductions 
and growth experiments ESGRO recombinant Mouse LIF protein (ESG1107) 
was obtained from Merck. The small molecule inhibitors PD0325901 (#1408) 
and CHIR99021 (#1386) were obtained from Axon Medchem, and PD173074 
(S1264) from Selleckchem. 
COS7 were transfected using the Fugene 6 transfection reagent in accordance 
with the manufacturer’s instructions (Roche Molecular Biochemicals) at 
approximately 50% confluence, were incubated for 72 hrs with 2 g of 
supercoiled plasmid DNA complexed with 5 l Fugene and then harvested for 
protein analysis. Transfected ESC were obtained by incubating the cells (0.5-1 
x 106 cells per well of 6-well dish) with 5 g of plasmid DNA using Lipofectamine 
2000 reagent (Life Technologies) for 36 hours. ESC clones stably transfected 
with Gab1 expression vectors were selected in ESC medium containing 
Puromycin (1 g/ml) or Hygromycin (100 g/ml) (for 10 days, then trypsinised 
and combined to establish pooled cultures for each construct.  For growth factor 
induction experiments ESCs were cultured overnight in GMEM base medium 
lacking glutamine and serum prior to stimulation with growth factors. E14/T cells 
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were super-transfected with supercoiled plasmids carrying the polyoma origin 
of replication as described previously. 
Cloning Gab1 cDNAs and expression constructs 
The mouse Gab1 cDNA was generated by RT-PCR using a Superscript 
preamplification system (Invitrogen) to reverse transcribe 1ug of total RNA from 
C3CH10T1/2 fibroblasts. 1/10th of the reaction was amplified using Expand 
High fidelity polymerase (Roche) with  5’ 
GGGCGGCCGCCGCACCATGAGCGGTGGTGAAGTG  and 3’ 
CCCTCGAGTCACTTCACATTCTTGGTGGGTG oligonucleotide primers 
containing Not1 and Xho1 restriction sites respectively (underlined). Thirty 
cycles of PCR generated the expected 2 kb DNA fragment, which was restricted 
with Not1 and Xho1, subcloned and sequenced. Gab1 cDNAs were isolated 
from an ESC cell cDNA library provided by Dr Hitoshi Niwa. Three independent 
clones were sequenced at their 5’ and 3’ ends and one clone sequenced on 
both strands of the coding region. Gab1 and Gab1 cDNAs were restricted 
with Not1 and Xho1 and subcloned into pCAGIH a hygromycin resistant 
derivative of the pCAGIZ expression vector  (Jackson et al., 2002; Niwa et al., 
1998). This plasmid contains the SV40 origin sequence, allowing efficient 
transgene expression in cells harbouring the SV40 large T antigen. A 
progressively truncated series of Gab1 cDNAs, M104, M151, M232, and M240 
were generated by PCR amplification. Reactions were performed with a 5’ 
primer containing a Not1 restriction site and Kozak consensus immediately 
upstream of the ATG initiation codon plus 16-19 nucleotides of downstream 
Gab1 sequence and a 3’ primer containing an Xho1 restriction site. The 
amplified products were subcloned into the pCAGIH expression vector as 
Not1/Xho1 fragments. Gab1-EGFP or Gab1-myc tagged fusion proteins were 
generated by PCR amplification of Gab1 regions cloned in  pCAGIH (or puro 
version pCAGIP)  modified vectors,  upstream of a an open reading frame 
containing either a poly glycine- EGFP protein, or a triple myc-tag respectively. 
The 15aa N-terminal region of Gab1 was cloned upstream of EGFP as a 
double stranded oligonucleotide. The sequences of the oligonucleotide primers 
used to generate the Gab1 coding regions are available on request. Gab1 
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expression vectors were linearised with Sfi1 prior to transfections. Drug 
resistant ESC colonies were picked individually or pooled to establish stably 
transfected cultures. 
Preparation of embryonic RNA and RT-PCR analysis 
Embryos and cells were prepared from appropriately staged 129 female mice. 
After flushing from the oviduct, oocytes were treated with hyaluronidase to 
remove cumulus cells. Both oocytes and blastocysts were washed extensively 
to eliminate contaminating cellular debris prior to lysis. Primordial germ cells 
(PGCs) were isolated from the dissected genital ridges of day 12.5 embryos, 
using calcium and magnesium free phosphate buffered saline (Buehr and 
McLaren 1993). Freshly prepared oocytes (n=35), blastocysts (n=30) and 
PGCs were lysed in Solution D and RNA was purified by acid phenol extraction 
(Chomczynski and Sacchi, 1987). To aid recovery of RNA, 20 g of carrier tRNA 
was added to the samples prior to extraction. cDNA was prepared from 1/5th of 
the recovered RNA using random priming and the Superscript Preamplification 
system. 1/10th of the reverse transcription reaction was then amplified using 
AmpliTaq Gold polymerase (Perkin Elmer). PCR reactions of 50 cycles were 
performed using primers that amplify a 184 bp DNA fragment from 
Gab1cDNA (GGACCATTCGAGGTGGCAGAC; 
CAACCCAGCATCAACTTGCTGAC) or a 939 bp DNA fragment from -actin 
cDNA (GTGACGAGGCCCAGAGCAAGAG; 
AGGGGCCGGACTCATCGTACTC). 
Disruption of Gab1 expression by homologous recombination 
Genomic DNA spanning the Gab1exon was obtained by screening the 
RPC121 Mouse PAC library obtained from UK HGMP Resource Centre 
(Osoegawa et al., 2000) with the 32P end-labelled Gab1 oligonucleotide 
TACTCAGGTGTCATGCGTCTGCCACCTCGAATGGT. A ~ 7 kb Xba1 DNA 
fragment encompassing the Gab1 exon was isolated from the PAC clone 340-
d21, cloned into pBS and sequenced using the Genome Priming System (New 
England Biolabs). ET-cloning using bacterial recombination was used to 
introduce a kanamycin gene into the Gab1 exon to create a unique BamH1 
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site into which a PGK polyadenylation signal was cloned (Muyrers et al., 1999). 
This sequence was amplified with a 5’ primer incorporating BamH1 and Sal1 
restriction sites and 3’ primer containing a Bgl11 site. Hygromycin, and 
blasticidin selection markers were then individually cloned as BamH1, Sal1 
fragments immediately upstream of the PGK sequence to generate three 
targeting vectors. Plasmid was digested with Xba1, to free the targeting vector 
from the plasmid backbone, prior to transfections. In transfections either 1 x 108 
ESC were electroporated (800V, 3 F) with 150 g linearised plasmid or 1 x 
107 cells were electroporated (240 V, 500 F) with 40 g linearised plasmid. 
Cells were plated at 2-3 x 106 cells per 10 cm dish and 48 hours later treated 
with medium containing either Blasticidin (10 g/ml), Hygromicin (100 g/ml) or 
G418 (200 g/ml). After ~ 10 days selection colonies were picked and 
expanded for freezing and DNA analysis. Genomic DNA was prepared from 
clones grown to confluency in 24-well plates using Proteinase K digestion 
followed by isopropanol precipitation. Approximately 1/5th of the resuspended 
DNA was restricted with EcoRV , transferred to an uncharged Nylon filter 
(Amersham) by Southern blotting and hybridised with DNA probes, located 
either 5’ or 3’ of the targeting construct, generated by PCR (5’ probe primers: 
AGAGTCCTGTTGTATGCCTGG, CAAGTACTCCTTACTGCCCAG; 3’ probe 
primers:  GACTCACCAGAAATGGGGTTC, AGGTGATGTGGTTTCATGTAG) .  
ESC Self-renewal assays 
To compare stem cell self-renewal between wild-type and Gab1 mutant IOUD2 
cells Oct4--galactosidase activity was quantitated as described previously 
(Burdon et al., 1999). ESC were plated in 24 well plates (5000 cells/well), 
cultured for 6-days and -galactosidase activity in lysates was measured using 
the ONPG assay. Specific enzyme activity was normalised relative to the 
protein concentration of lysates and standardised against a serial dilution of 
purified -galactosidase enzyme (Promega). Triplicate samples were assayed 
as duplicates.  
Alkaline phosphatase activity was assayed in ESC lysates prepared from cells 
in 24-well plates (described above), using 1 ml of 1 mM MgCl2/0.2% NP-40 per 
well and incubated for 2 hours at 37oC. Duplicate aliquots (80 l) were mixed 
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with 10 l Glycine buffer (1M Glycine, 10 mM ZnCl2, 10 mM MgCl2), and 10 ml 
of 100 mM p-nitrophenyl phosphate (Sigma), incubated in a 96-well plate for 
20-60 minutes and the absorbance was read at 405 nM.  
Cell growth/proliferation assay 
Cells were plated onto uncoated tissue culture 96-well plates at 20,000 or 
40,000 cells per well in 100 l of growth medium, and cell growth was assayed 
using the CyQuant Direct Cell Proliferation Assay (C35011 ThermoFisher 
Scientific) to measure live cell associated DNA fluorescence.  Each sample, 
was assayed by addition of 100 l of 2x detection reagent (0.4 l Direct DNA 
stain, 2 l Direct Background suppressor diluted in 100 l Opti-MEM 
ThermoFisher Scientific 11058021), incubated for 1 hr at 370C in the incubator 
and then read on Victor Multi Label Counter from the bottom of plates with 
standard green filter at 508/527 nM excitation/emission wavelengths. Each cell 
line sample or treatment was measured in a minimum of four independent wells 
for each experiment. 
Cell cycle analysis 
Single cell suspensions of cells were fixed in 70% ethanol, rehydrated in 
phosphate buffered saline for 30 mins at 4o, rinsed twice with PBS and then 
incubated with 100 g DNAse free RNAse for 1 hr at room temperature. 
Propidium iodide (final concentration 50 g/ml) was added to the cells for 10 
minutes before flow analysis (Fortessa X-20, Becton Dickinson: 561 nM laser, 
emission 610 nM). Data was acquired using FACSDiva software (Becton 
Dickinson). The cytometer was set to linear fluorescence for optimal resolution 
for DNA, and data collected for 50,000 events per sample. The percentages of 
G0, G1, S and G2 phases were manually determined using FlowJo 10 software.   
Apoptosis and cytotoxicity assays 
Single cell suspensions containing 1 x 105 cells/sample, as well as apoptosis 
control treated with Staurosporine ( 1 M: 1 hr), and dead cell control (2% 
DMSO: 1 hr) were stained using the Annexin V – APC Kit (Biolegend) according 
to the manufacturer’s instructions. Cells were washed once with Annexin V 
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Binding buffer, then resuspended in 100 l of the same buffer and stained using 
5 l Annexin V reagent. Samples were incubated for 15 minutes in the dark and 
then diluted with 400 l binding buffer and adjusted to 50 mg/ml Propidium 
Iodide, prior to flow analysis on a Fortessa cytometer (Becton Dickinson: 640 
nM laser, emission 670 nM ). Data analysis was carried out using FlowJo 10 
software.  
For assessing Apoptosis/Cytotoxicity/Viability we used the ApoTox-Glow 
Triplex Assay (Promega G6320) according to the manufacturer’s instructions. 
Cells were plated at 40,000 cells in 100 l medium, per well of tissue culture 
96-well plates and grown for 2 further days. The Viability/Cytotoxicity reagent 
(20 l) was added to each well, mixed by orbital shaking and incubated for 30 
minutes at 370C and then read at 405 nM (excitation)/505 nM (emission) for 
Viability, and 485 nM (excitation)/ 520 nM (emission) using a BioTek Synergy 
Ht plate reader. To measure apoptosis, Caspase-Glo reagent (100 ml) was 
added to each well, mixed by orbital shaking, incubated at room temperature 
for 30 minutes and the luminescence was read using the Biotek Synergy Ht 
plate reader. Ethanol (0.7%: 1 hr) and Staurosporine (1 mM: 1 hr) treated cells 
served as cell death and apoptosis controls respectively.  
Northern analysis of RNA  
RNA was prepared from cells lysed in acid guanidinium hydrochloride 
(Chomczynski and Sacchi, 1987). Northern blots were produced from samples 
containing 10 g of total RNA probed with the 32P-labeled Gab1 cDNA. 
Quantitative reverse transcriptase PCR 
RNA (1 g) purified using RNeasy Mini Kit (Qiagen) was used to sythesise 
cDNA using SuperScript First-Strand Synthesis System (Invitrogen). 
Approximately 1/60th of the cDNA was amplified using Platinum SYBR Green 
QPCR kit (Invitrogen) using the conditions; 50oC for 2 minutes then 95oC for 2 
minutes followed by 40 cycles of 95oC for 15s then 60oC for 30s, with a final 
cycle consisting of 95oC for 1 minute, 60oC for 30s and 95oC for 15s.  Gab1 
isoform specific forward primers were:  GGAGAAGAAGTTGAAGCGTTA, 
GACGCATGACACCTGAGTA. The common reverse primer was: 
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GCAACACAAACCACCTTCT. -actin control primers were: forward 
TGACAGGATGCAGAAGGAGA, reverse GTACTTGCGCTCAGGAGGAG.  
Immunoprecipitation and Immunoblotting 
Immunoprecipitations were performed essentially as described previously 
(Burdon et al., 1999). ESC (5 x 106) were plated overnight in 10 cm diameter 
dishes. The cells were serum and cytokine starved for 24 hrs prior to induction 
with growth factors. Cells were lysed in 0.6mls ice-cold lysis buffer (150 mM 
NaCl, 10 mM Tris-HCl, pH 7.4, 0.5% NP40, 1 mM NaVO4, 1 mM EDTA, 0.5 mM 
PMSF), cleared of nuclear and cytoplasmic debris and then incubated with  
~1g antibody and protein A sepharose for 4-16 hrs at 40C. Immune complexes 
were washed extensively and then boiled in SDS-sample buffer prior to gel 
electrophoresis. For protein analysis in whole cell lysates, ESC were plated at 
5 x 106 cells per well in 6-well dishes. After plating overnight and a further 24 
hours in serum-free medium, cells were stimulated with growth factors, washed 
once with PBS and lysed in 100 or 200 l of SDS-sample buffer. These lysates 
were sonicated and boiled prior to loading on gels. Following electrophoresis 
on 8 or 10% denaturing SDS-polyacrylamide gels, proteins were electroblotted 
onto ECL-nitrocellulose filters (Amersham) and probed with antibodies (diluted 
1:1000). The antibodies used in this study were obtained from New England 
Biolabs/Cell Signalling Technology: phospho-Erk  9101; phospho-Akt 
(Ser473) #4058, phospho Gab1 Tyr307 #3234; phospho Gab1 Tyr627 # 3231; 
phospho Stat3 #9131, #9138 BD/Transduction Labs: Erk2 E16220; Stat3 
S21320; Grb2 G16720, Upstate Biotechnology: phosphotyrosine 4G10, Gab1 
CT 06-579; p85 #06-195, Santa Cruz: SHP2 sc-280; Myc sc-40; Oct4 sc-5279 
. A rabbit polyclonal anti-Gab1 antibody was very generously provided by T. 
Hirano and M. Hibi (Takahashi-Tezuka et al., 1998).  
Immunocytochemistry and Confocal microscopy 
Approx 1 x 106 cells in 500 l of medium  were allowed to attach to glass 
coverslips (pretreated with 1% gelatin) in the bottom of a  6-well culture dish for 
1 hour. Wells were then flooded with medium and the cells cultured overnight. 
Cell on the cover slips were fixed for 10 minutes in 4% paraformaldehyde at 
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room temperature, gently washed  5 times with PBST (PBS, 0.03% TritonX-
100), and then incubated with blocking solution (PBST, 3% goat serum, 1% 
BSA) for one hour at room temperature. Primary antibodies were diluted in 
blocking solution and applied overnight at 4oC, followed by four washes with 
PBST. Appropriate secondary antibodies were diluted 1:1000 in blocking 
solution and applied for one hour, at room temperature in the dark. The cells 
were washed extensively with PBST, and the final wash contained 10µg/ml 
DAPI. The antibodies used were Oct4  primary antibody at 1:200 (Santa Cruz, 
sc5279) with goat-anti-mouse IgG2b secondary antibody, rabbit anti-Gab1 
antibody (gift of T. Hirano) at 1:500 (Takahashi-Tezuka et al., 1998). The 
coverslips were then laid over the depression in a concave microscope slide 
filled with 150 l PBS and imaged using a Nikon EC1 confocal microscope at 
60x magnification. For imaging live cells on microscope slides, cells were 
maintained in Opti-MEM (Life Technologies). 
 
3H palmitate labelling 
Transfected cells were incubated for 4 hours in media containing 0.5mCi/ml 3H 
palmitic acid (Perkin Elmer) and 0.1% BSA (fatty acid-free). The GFP-tagged 
proteins were then immunoprecipitated with magnetic microbeads coupled to 
GFP antibody (Miltenyi Biotech). Immunoprecipitated proteins were separated 
by SDS-PAGE and transferred to nitrocellulose membranes. 3H-palmitate 
present on the recovered GFP-tagged proteins was detected using a Kodak 
Biomax Transcreen LE intensifier screen. 
 
Statistical Methods 
Cell growth data was analysed using mixed models to allow for random 
variability in the group effects occurring between the replicate experiments. The 
models fitted: group, day and the group.day interaction as fixed effects; and 
replicate, replicate.group, replicate.day and replicate.group.day as random 
effects. A different residual variance was allowed for each day of the trial, after 
checking this led to a significant improvement in the model compared to a model 
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using a constant residual variation, using a likelihood ratio test. In order to 
satisfy normality assumptions, a log transformation of the data was used for all 
analyses except that for Figure 3b where a square root transformation was 
preferable. t-tests were defined with the models to carry out pairwise 
comparisons of specified groups on each day of the trial. 
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Figures 
 
 
 
 
 
 
 
 
 
FIGURE 1. Expression profile of a novel Gab1 variant protein. (A) Gab1 
Western blot analysis of whole cell lysates from ESC (ES), embryonal 
carcinoma (EC), 10T1/2 embryonic fibroblasts (fb) and pooled E12.5 embryo 
tissues (em). The positions of the 110 and 95 kDA Gab1 proteins are identified. 
(B) Schematic of the Gab1 gene locus, showing the location of the transcription 
start sites for Gab1 and Gab1, and the exons.  (C) Schematic showing the 
structure of Gab1 and Gab1 proteins. Dark grey, and light grey designated 
areas are proline rich regions and the Met binding domain (MBD), respectively. 
(D) Gab1 and Oct4 Western blots of whole cell lysates of ESC (ES), primary 
embryonic fibroblasts (fb), pre-iPS cells (pr), iPSCs reprogrammed in 2i 
medium (2i) or serum/LIF medium (sr) and an epiblast stem cell line (Epi). (E) 
Quantitative RT-PCR analysis of Gab1 and Gab1 expression in ESCs (ES) 
transitioned into epiblasts stem cells (Epi) and embryoid bodies (EB). Results 
represent means +/- 1 SD from one experiment. Expression is normalised 
relative to the level in ESCs.   
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FIGURE 2. Gab1 as an ESC signal transducer. (A) Western blot of Gab1 
immunoprecipitates from unstimulated ESC (-)  or ESCs stimulated with serum 
(sr)  or LIF (lf) for 10 minutes, probed with Gab1pY627, Gab1pY307, 
phosphotyrosine, and Gab1 specific antibodies. The dashes identify 100kDa. 
(B)  Western blot of SHP2 immunoprecipitates from cells treated as in (A) 
probed with Gab1 and SHP2 antibodies. (C) Western blot of cell lysates from 
wild type ESC, and Gab1 knock-out ESC line stably transfected with empty 
vector (-/-), Gab1, and Gab1expression vectors, unstimulated or following 
stimulation with LIF for 15 minutes. The blot was incubated with antibodies to 
phospho-Akt, Akt, phospho-Erk, Erk1/2, phospho-Stat3 and Gab1. 
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FIGURE 3. Gab1 function in ESC. (A) Undifferentiated ESC identified by 
alkaline phosphatase activity (pink stain) in two Gab1 heterozygous (HET) and 
two Gab1 knock-out (KO) E14Tg2a cell lines 5 days after plating. Scale bars 
= 200 m  (B) Growth curves of Gab1 heterozygous (HET) and Gab1 knock-
out (KO) E14Tg2a cell lines measured by DNA-dependent fluorescence in live 
cells. Cells were plated at a density close to that for routine passaging of ESCs 
( 6 x104 cells/cm2) and the DNA fluorescence was measured daily for 6 days. 
The data represents the mean of three independent experiments +/- s.e.m. 
Statistical analysis by t-test showed significant differences  between the 
averages for the HET and KO lines  from day 3 to day 6 (p≤ 0.005). (C) Growth 
curves performed as described in (B) with pooled transfected ESCs that were 
Gab1 heterozygous (HET-mCherry), Gab1 knock-out (KO-EGFP) and 
Gab1 knock-outs stably expressing Gab1 from a cDNA expression vector 
(KO-Gab1). t-test analysis showed significant differences between the KO-
EGFP and KO-Gab1 lines from day 4 to day 6 (p<0.0001), but not between 
HET-mCherry and KO-Gab1 cells.    
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FIGURE 4. Gab1 regulation of ESC cell cycle and apoptosis. 
(A) Cell cycle analysis of Gab1 expressing or non-expressing ESC by flow 
cytometry. Triplicate ESC samples were collected at day 2 and 3 of culture, 
fixed and stained using propidium iodide, and analysed by flow cytometry. 
Representative scans are shown and sub-diploid cell material is identified by 
the asterisk. (B) Quantitation of cell cycle distribution. Mean values of cell cycle 
phases +/- 1 SD generated from three independent cultures (* t-test p<0.005).  
(C) Flow cytometry of Annexin V staining in day 1 and day 2 ESC cultures. Grey 
and black bars are values from Gab1 KO and Gab1 expressing (Gab1 KO 
+ Gab1 cDNA vector) ESCs respectively (* t-test p<0.005).  (D) Apoptosis, 
cytotoxicity and viability assays of day 2 cultures of Gab1 KO and Gab1 
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expressing ESCs. Values are means of 4 biological replicates +/- 1 SD 
(apoptosis and cytotoxicity t-tests p<0.0001; viability t-test p<0.005).  
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FIGURE 5.  Gab1 and ESC response to nutrient availability. 
(A) Growth profiles of Gab1 KO and Gab1 expressing ESCs treated with 25 
nM mTOR inhibitor INK128 (mTORi). Values are means of three independent 
experiments +/- s.e.m. (B, C) Growth of Gab1 KO and Gab1b expressing ESC 
cultures supplemented on day 2 with either 10 l PBS, regular DMEM (+), or 
DMEM (-) lacking glucose, glutamine, and sodium pyruvate. Values are means 
of three biological replicates +/- 1 SD.    
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FIGURE 6.  Gab1 mediated ESC survival dependency on LIF, and rescue 
by Mek inhibition. Growth profiles of Gab1 KO and Gab1 expressing ESCs 
cultured in:  (A) the presence or absence of LIF (+/- 1 M PD0325901 Mek 
inhibitor);  (B) 2i (1 M PD0325901 Mek inhibitor, 3 M CHIR99021 GSK3 
inhibitor) +LIF serum free medium;  (C) +/- FGFR inhibitor PD173074 (one 
experiment with quadruplicate biological samples; and (D) +/- 1 M PD0325901 
Mek inhibitor. Data points in graphs A, B and D represent the means of three 
independent experiments +/- s.e.m. Data points in graph C represent the means 
from four biological replicates in one experiment. For all graphs t-tests showed 
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statistically significant differences between serum+LIF treated KO and 
KO+Gab1 control lines at days 4-6 (p≤ 0.0001), and between KO control and 
KO treated cells (p≤ 0.0001). 
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FIGURE 7. Localisation of Gab1 at the cell membrane. Confocal images of 
(A) Wild type ESC, (B) Gab1 knock-out ESC and (C) Gab1 knock-out ESC 
stably transfected with a Gab1 cDNA expression vector,  immunostained with 
antibodies against Gab1 (red) and counter-stained for DNA with Dapi (Blue). 
Confocal images of EGFP fluorescence in ESC stably expressing the following 
Gab1-EGFP fusion proteins:  (D) Gab1-EGFP; (E) Gab1-EGFP; (F) N-
terminal EGFP-Gab1 (G) Gab1-EGFP fusion lacking 15 N-terminal amino 
acids; (H) the 47 N-terminal amino acid peptide of Gab1 fused to EGFP; and 
(I) 15 N-terminal amino-acid peptide of Gab1 fused to EGFP. White arrows 
highlight consitently observed intracellular accumulations of Gab1 proteins. 
Scale bars = 10 m.  
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FIGURE 8. N-terminus of Gab1 directs palmitoylation and is required for 
membrane localisation and function.  (A) Schematic outlining the structure 
of the Gab1 PH domain and comparison of the N-terminus of Gab1 with 
corresponding regions of other Gab-related proteins. The arrangement of the 
seven -sheets and the -helix, and relative positions of a putative nuclear 
localisation sequence and PIP3 binding residues are shown. Cysteines within 
the -helix are highlighted in bold. (B) EGFP immunoprecipitates from ESC 
stably transfected with EGFP or Gab1-EGFP fusion proteins cultured overnight 
with 3H- palmitate, were fractionated on an SDS protein gel, transferred to a 
filter and autoradiographed (upper panel) and probed for EGFP protein (lower 
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panel).  CA3 designation identifies variants in which the three N-terminal 
cysteines of Gab1 are substituted with alanine (C) Confocal images of EGFP 
fluorescence in ESC transfected with the 47-EGFP, 47CA3-EGFP, PH domain-
EGPF and PH domain CA3-EGPF fusion proteins (counter-stained with Dapi). 
Scale bars = 10 m. (D) Growth curves of Gab1 knock-out (KO) ESC and 
Gab1 knock-out ESCs stably transfected with either Gab1 wild-type or CA3 
mutant cDNA expression vectors. The graphs represent the means obtained 
from three independent experiments +/- s.e.m. t-test analysis showed 
significant differences between the KO and KO-Gab1 lines from day 4 to day 
6 (p<0.0001), but not between KO and KO-Gab1:CA3m cells 
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J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
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SUPPLEMENTARY FIGURE 1.  Expression of a novel form of Gab1. (A)  Western 
blot showing Gab1 protein expression in whole cell lysates prepared from 
undifferentiated ESCs, ESCs at 2, 4, 6 and 8 days during embryoid body differentiation 
in suspension culture. (B) Northern blot of total RNA prepared from ESC and day 8 
embryoid body hybridised with Gab1 cDNA probe. The position of the 28S ribosomal 
RNA (approx. 5 kb) identified by ethidium bromide staining of the filter prior to 
hybridisation is indicated (C) Alignment of Gab1 ESTs which have a non-coding 5’ 
exon analogous to Gab1β that have been identified in different species. (D) Gab1 
proteins produced by COS7 cells transfected with Gab1α and β cDNAs where 
translation initiates at methionines 104, 151, 232 or 240. (E) H3K4me3 and H3K27me3 
histone modifications at the mouse Gab1 locus in ESC and EpiSCs visualised in the 
UCSC genome browser. Whereas a region adjacent to the Gab1β exon is enriched for 
the H3K4me3 mark indicative of active transcription, the corresponding region at the 
Gab1α exon is enriched for both active and repressed (H3K27me3) modifications 
(bivalent). The RNA-seq track in ESC demonstrates that the Gab1 locus is 
transcriptionally active (from right to left). 
J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
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J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
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SUPPLEMENTARY FIGURE 2. Gab1β expression profiles. (A) Reverse 
transcriptase PCR analysis of Gab1β expression in embryonic cells. Gab1β 
expression was analysed in cDNA prepared from ESC (0.2-100 ESC equivalents), 
unfertilised oocytes, blastocysts and primordial germ cells (PGCs) and NIH3T3 
fibroblasts (equivalent to 100 cells). Gab1β, and β-actin specific primers generated 
184 bp and 939 bp amplicons, respectively. (B) Western blot of Gab1 protein 
expression in whole tissue lysates prepared from adult mouse. (C) Quantitative 
transcription start site expression at the mouse Gab1 gene locus derived from 
FANTOM5 mouse Cap Analysis of Gene Expression (CAGE) data analysis. The upper 
sections describes the summary of transcription initiation at Gab1α and Gab1β 
transcription start sites (TSS) combining cumulative CAGE data from over 1000 
individual mouse cell and tissue samples visualised in the ZENBU genome browser. 
The tissues/cell types with the highest expression (in descending order) for Gab1α 
and Gab1β TSS is presented as normalised tags per million counts (purple bars on 
right) for each sample.   
J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
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J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
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SUPPLEMENTARY FIGURE 3. Analysis of Gab1β signalling (A) Western blots of 
PI3K p85 immunoprecipitates from unstimulated ESC (-)  or ESCs stimulated with 
serum (sr)  or LIF (lf) for 10 minutes,  incubated with Gab1 and p85 antibodies; and 
cell lysates generated in (A) incubated with antibodies against phospho-Stat3 (Y705) 
and phospho-Erk. (B) Western blot of anti-myc immunoprecipitates prepared from 
ESCs transfected with empty (vec), myc epitope-tagged Gab1α and myc epitope-
tagged Gab1β expression vectors, incubated with antibodies against Shc, Grb2 and 
Gab1. (C) Schematic showing the Gab1 gene locus and targeting vector used to insert 
the blastocydinR selection cassette into the Gab1β first exon. Location of external 
probes used to screen for targeted insertion of the selection cassette are shown as 
black bars. (D) Southern blot of EcoRV digested genomic DNA prepared from IOUD2 
Gab1β wild-type ESC (+/+), heterozygous Gab1β-blastocidinR, Gab1β-hygromycinR 
clones (+/-) and a double targeted Gab1β-blastocidinR/Gab1β-hygromycinR 
homozygous Gab1β null clone (-/-),  hybridised with a 32P-labelled Gab1 5’ external 
probe. (E) Western blot of Gab1 and Oct4 protein expression in whole cell lysates from 
Gab1β wildtype, Gab1β heterozygous and Gab1β null ESCs. (F, G) Western blot 
analysis of phospho-Erk, Erk2 and phospho-Stat3 (Y705) in cell lysates prepared from 
Gab1β wild-type, heterozygous and homozygous null ESCs following stimulation with 
LIF or Serum for 0,5,10 and 15 minutes. 
J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
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SUPPLEMENTARY FIGURE 4. Role of Gab1β in ESC self-renewal. (A) Self-renewal 
response to LIF titration in two Gab1β wild-type (darker shaded bars) and Gab1β KO 
(light shaded grey bars) IOUD2 cell lines as measured by pou5F1-LacZ activity in day 
5 low density cultures at early and late passages. Data represents the means ± SD of 
three biological replicates. (B) Southern blot of EcoRV digested genomic DNA 
prepared from E14Tg2a wild-type ESC (WT), three heterozygous Gab1β-hygromycinR 
clones (HET) and three Gab1β-blastocidinR/Gab1β-hygromycinR homozygous Gab1β 
null clones (KO) ,  hybridised with a 32P-labelled Gab1 5’ external probe. (C) Western 
blot of Gab1 and Oct4 protein expression in cell lysates prepared from E14Tg2a 
Gab1β HET and KO clones. (D) Self-renewal response to LIF titration in Gab1β HET 
(dark bars) and Gab1β KO (white bars) E14Tg2a ESCs as measured by alkaline 
phosphatase activity. Data represents the means ± SD of three biological replicates. 
J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
SUPPLEMENTARY FIGURE 5. Assessment of the factors that may limit ESC 
growth in near-confluent cultures.  (A) Growth of Gab1β KO,  Gab1β expressing, 
and Gab1β Heterozygous ESCs at 3 days in culture, and then after supplementation 
with 10 µl PBS or PBS containing 1 mM or 2 mM Sodium Pyruvate, or 2 mM or 4 mM 
Glutamine, or 10 µl GMEM and cultured for a further 24 hrs.  
J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
SUPPLEMENTARY FIGURE 6. Effect of LIF titration on growth of Gab1β KO and 
Gab1β expressing ESCs. Growth profiles of (A) Gab1β KO and (B) Gab1β expressing 
ESCs cultured in the presence 0, 20, 100 and 1000 units/ml of LIF for 6 days. The 
values represent the means of four biological replicate cultures +/- SD.  For reference, 
the dark line in (A) is comprised of the values obtained from the Gab1β expressing 
ESCs grown in 1000 units/ml LIF , and in (B) the grey line is the KO cells grown in 
1000 units/ml LIF.   
J. Cell Sci.: doi:10.1242/jcs.222257: Supplementary information
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